Foresite Capital Management IV’s Cymabay Therapeutics CBAY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q4 | – | Sell |
-1,787,094
| Closed | -$26.6M | – | 7 |
|
|
2023
Q3 | $26.6M | Hold |
1,787,094
| – | – | 14.8% | 2 |
|
|
2023
Q2 | $19.6M | Hold |
1,787,094
| – | – | 9.62% | 6 |
|
|
2023
Q1 | $15.6M | Hold |
1,787,094
| – | – | 8.09% | 7 |
|
|
2022
Q4 | $11.2M | Hold |
1,787,094
| – | – | 4.79% | 7 |
|
|
2022
Q3 | $6.26M | Hold |
1,787,094
| – | – | 2.01% | 7 |
|
|
2022
Q2 | $5.27M | Hold |
1,787,094
| – | – | 1.42% | 7 |
|
|
2022
Q1 | $5.56M | Hold |
1,787,094
| – | – | 1.55% | 8 |
|
|
2021
Q4 | $6.04M | Hold |
1,787,094
| – | – | 1.24% | 9 |
|
|
2021
Q3 | $6.52M | Hold |
1,787,094
| – | – | 0.96% | 10 |
|
|
2021
Q2 | $7.79M | Hold |
1,787,094
| – | – | 1.05% | 11 |
|
|
2021
Q1 | $8.11M | Hold |
1,787,094
| – | – | 0.97% | 11 |
|
|
2020
Q4 | $10.3M | Hold |
1,787,094
| – | – | 1.11% | 11 |
|
|
2020
Q3 | $12.9M | Sell |
1,787,094
-1,056,799
| -37% | -$7.65M | 2.92% | 10 |
|
|
2020
Q2 | $9.93M | Buy |
+2,843,893
| New | +$9.92M | 4.83% | 8 |
|
|
2020
Q1 | – | Sell |
-2,315,016
| Closed | -$4.54M | – | 17 |
|
|
2019
Q4 | $4.54M | Buy |
2,315,016
+254,748
| +12% | +$499K | 1.96% | 13 |
|
|
2019
Q3 | $10.5M | Sell |
2,060,268
-510,990
| -20% | -$2.62M | 3.41% | 13 |
|
|
2019
Q2 | $18.4M | Sell |
2,571,258
-60,000
| -2% | -$430K | 5.2% | 7 |
|
|
2019
Q1 | $34.9M | Hold |
2,631,258
| – | – | 12.56% | 2 |
|
|
2018
Q4 | $20.7M | Buy |
2,631,258
+607,889
| +30% | +$4.78M | 9.5% | 4 |
|
|
2018
Q3 | $22.4M | Hold |
2,023,369
| – | – | 7.35% | 6 |
|
|
2018
Q2 | $27.2M | Sell |
2,023,369
-88,500
| -4% | -$1.19M | 9.26% | 5 |
|
|
2018
Q1 | $27.4M | Sell |
2,111,869
-142,633
| -6% | -$1.85M | 11.37% | 3 |
|
|
2017
Q4 | $20.7M | Buy |
+2,254,502
| New | +$20.7M | 14.54% | 3 |
|